JP2023090955A5 - - Google Patents

Download PDF

Info

Publication number
JP2023090955A5
JP2023090955A5 JP2023078304A JP2023078304A JP2023090955A5 JP 2023090955 A5 JP2023090955 A5 JP 2023090955A5 JP 2023078304 A JP2023078304 A JP 2023078304A JP 2023078304 A JP2023078304 A JP 2023078304A JP 2023090955 A5 JP2023090955 A5 JP 2023090955A5
Authority
JP
Japan
Prior art keywords
clostridial toxin
amino acid
modified clostridial
modified
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023078304A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023090955A (ja
Filing date
Publication date
Priority claimed from JP2019147451A external-priority patent/JP6867452B2/ja
Application filed filed Critical
Priority to JP2023078304A priority Critical patent/JP2023090955A/ja
Publication of JP2023090955A publication Critical patent/JP2023090955A/ja
Publication of JP2023090955A5 publication Critical patent/JP2023090955A5/ja
Pending legal-status Critical Current

Links

JP2023078304A 2019-08-09 2023-05-11 陽イオン性神経毒 Pending JP2023090955A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023078304A JP2023090955A (ja) 2019-08-09 2023-05-11 陽イオン性神経毒

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019147451A JP6867452B2 (ja) 2019-08-09 2019-08-09 陽イオン性神経毒
JP2021063847A JP7328275B2 (ja) 2019-08-09 2021-04-05 陽イオン性神経毒
JP2023078304A JP2023090955A (ja) 2019-08-09 2023-05-11 陽イオン性神経毒

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021063847A Division JP7328275B2 (ja) 2019-08-09 2021-04-05 陽イオン性神経毒

Publications (2)

Publication Number Publication Date
JP2023090955A JP2023090955A (ja) 2023-06-29
JP2023090955A5 true JP2023090955A5 (enExample) 2024-03-07

Family

ID=68768346

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019147451A Active JP6867452B2 (ja) 2019-08-09 2019-08-09 陽イオン性神経毒
JP2021063847A Active JP7328275B2 (ja) 2019-08-09 2021-04-05 陽イオン性神経毒
JP2023078304A Pending JP2023090955A (ja) 2019-08-09 2023-05-11 陽イオン性神経毒

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2019147451A Active JP6867452B2 (ja) 2019-08-09 2019-08-09 陽イオン性神経毒
JP2021063847A Active JP7328275B2 (ja) 2019-08-09 2021-04-05 陽イオン性神経毒

Country Status (1)

Country Link
JP (3) JP6867452B2 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4746096A (en) * 1995-06-06 1996-12-24 Wisconsin Alumni Research Foundation Analogs of botulinum toxin and pharmaceutical compositions o f botulinum toxin
US20020127247A1 (en) * 2000-11-17 2002-09-12 Allergen Sales, Inc. Modified clostridial neurotoxins with altered biological persistence
US7172764B2 (en) * 2003-11-17 2007-02-06 Allergan, Inc. Rescue agents for treating botulinum toxin intoxications
CA2788074C (en) * 2010-01-25 2016-07-12 Allergan, Inc. Methods of intracellular conversion of single-chain proteins into their di-chain form

Similar Documents

Publication Publication Date Title
JP2024012421A5 (enExample)
AR132701A2 (es) Neurotoxinas catiónicas
JP2019528042A5 (enExample)
RU2017128211A (ru) Катионные нейротоксины
AR108689A1 (es) Neurotoxinas clostridiales quiméricas
FI3481852T3 (fi) Uusi botulinum-neurotoksiini ja sen johdannaisia
JP2005517627A5 (enExample)
JP6467000B2 (ja) 分解性クロストリジウム毒素
JP2019216735A5 (enExample)
RU2017134357A (ru) Сконструированный ботулинический нейротоксин
JP2016513082A5 (enExample)
RU2008140368A (ru) Peg-илированный мутированный токсин clostridium botulinum
US20240226250A9 (en) Modified neurotoxin single-chain polypeptide and use thereof
JP2023090955A5 (enExample)
EP2435091A2 (en) Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
EP3649143B1 (en) Novel recombinant botulinum neurotoxins with increased duration of effect
US20200048624A1 (en) Novel recombinant botulinum toxin with increased duration of effect
US20210008156A1 (en) Novel recombinant botulinum neurotoxins with increased duration of effect
Blitzer et al. Botulinum neurotoxin for head and neck disorders
US20200354706A1 (en) Novel recombinant botulinum toxin with increased duration of effect
US11453903B2 (en) Production of activated clostridial neurotoxins
JPWO2022189807A5 (enExample)
RU2023125554A (ru) Клостридиальные нейротоксины, содержащие экзогенную петлю активации
RU2025110789A (ru) Клостридиальные нейротоксины, содержащие активирующий сайт расщепления эндосомальной протеазой
RU2021111910A (ru) Терапевтическое и косметическое применение нейротоксина ботулина серотипа e